HEALTH ECONOMIC EVIDENCE ON NON-PHARMACOLOGICAL INTERVENTIONS FOR PERSONS WITH DEMENTIA- A SYSTEMATIC REVIEW
Author(s)
Nickel F, Kolominsky-Rabas PL
Interdisciplinary Centre for Health Technology Assessment (HTA) and Public Health (IZPH), Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany
OBJECTIVES: Over the last decade research on non-pharmacological interventions for persons with dementia (PwD) has gained momentum. The aim of this systematic review was therefore to assess the economic evidence on non-pharmacological interventions directly targeted at PwD. METHODS: A systematic literature search was conducted in the following databases: Cochrane Library, Centre for Reviews and Dissemination, EconLit, Embase, PsycINFO and PubMed. Trial-based economic evaluations published between 2010 and 2016 were included. Study quality was assessed according to the Drummond checklist. RESULTS: In total, nine RCT-based economic evaluations were identified. Of these, two studies evaluated exercise interventions for community-dwelling PwD. Considering the outcomes physical functioning and behavioral and psychological symptoms, these exercise programs were found likely to be cost-effective. Another study indicated that individually tailored occupational therapy for PwD exhibiting behavioral and psychological symptoms is cost-effective. Furthermore, the economic evidence on cognitive interventions was inconsistent. Joint reminiscence groups for community-dwelling PwD and informal caregivers as well as a carer-led individual cognitive stimulation therapy were unlikely to be cost-effective. In contrast, there is evidence that a group-based maintenance cognitive stimulation therapy for PwD residing in care homes or visiting day care centers is cost-effective. With regard to psychological and behavioral treatments two interventions, namely self-management group rehabilitation for PwD and their spouses as well as cognitive-behavioral therapy for PwD-caregiver dyads, demonstrated effectiveness and cost-neutrality. CONCLUSIONS: There is some evidence on cost-effective non-pharmacological interventions for PwD. However, the included studies showed a high degree of methodological heterogeneity with regard to outcomes, sample size, perspective and time horizon. In particular, quality-of-life values of PwD should be interpreted cautiously, this holds as well for proxy-rated values. This research work was funded by the Karl and Veronica Carstens-Foundation as part of the national graduate college ‘Optimisation strategies in Dementia – OptiDem’.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PMH27
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Mental Health